 CAMBRIDGE, Mass., Nov. 11, 2021 GLOBE NEWSWIRE -- Vericel Corporation NASDAQ:VCEL, a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on Thursday November 18th, at 10:00a.m. Eastern Time. 